ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1846

IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis

Huihua Ding1, Chandra Mohan1 and Tianfu Wu2, 1Biomedical Engineering, University of Houston, Houston, TX, 2Department of Biomedical Engineering, University of Houston, Houston, TX

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Biomarkers, diagnosis and lupus nephritis, SLE

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 9, 2015

Session Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Lupus nephritis (LN) is one of the most serious manifestations of systemic lupus erythematosus. Invasive renal biopsy remains the golden standard for the diagnosis and management of LN. The objective of this study is to validate serum IGFBP-2 as a novel biomarker of LN and to examine if it could reflect renal pathology in LN patients. 

Methods:

Serum samples from 85 biopsy-proven lupus nephritis patients, 18 chromic kidney disease (CKD) controls and 20 healthy controls were used for ELISA testing of IGFBP-2 levels. 

Results:

Compared to CKD patients of origins other than lupus or healthy controls, serum IGFBP-2 levels were significantly elevated in LN patients. Serum IGFBP-2 levels were able to discriminate LN patients from healthy controls with an Area Under the Curve (AUC) of 0.97 [95% CI: 0.93 to 1.00; P < 0.0001] and CKD disease controls (AUC: 0.65 [95% CI: 0.52 to 0.78; P = 0.043]). In addition, serum IGFBP-2 could serve as a potential indicator of both SLEDAI (active vs. inactive: 448.1 ± 51.9 ng/ml vs. 263.7 ± 41.7 ng/ml; P = 0.009) and rSLEADAI in LN patients (active vs. inactive: 429.1 ± 44.5 ng/ml vs. 213.3 ± 49.1 ng/ml; P = 0.007). Correlation analysis showed a significant correlation between serum IGFBP-2 levels and SLEDAI score (r = 0.379, P < 0.0001, n = 85) as well as rSLEDAI score (r = 0.409, P < 0.0001, n = 85). Serum IGFBP-2 levels also correlated well with serum creatinine levels (r = 0.658, P < 0.001, n = 85), urine protein-to-creatinine levels (r = 0.397, P < 0.001, n = 85), and eGFR levels (r = -0.680, P < 0.001, n = 85). More importantly, in 19 concurrent patients’ samples, serum IGFBP-2 correlate with the chronicity index of concurrent renal pathology (r = 0.576, P = 0.01). 

Conclusion:

Serum IGFBP-2 appears to be a promising biomarker for lupus nephritis, reflective of disease activity and chronicity changes in renal pathology.


Disclosure: H. Ding, None; C. Mohan, None; T. Wu, None.

To cite this abstract in AMA style:

Ding H, Mohan C, Wu T. IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/igfbp-2-as-a-novel-biomarker-for-disease-activity-and-renal-pathology-in-lupus-nephritis/. Accessed December 9, 2019.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/igfbp-2-as-a-novel-biomarker-for-disease-activity-and-renal-pathology-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.